Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 04 Feb 2022
First gene therapy for rare genetic neurodegenerative disorder in children, recommended in NICE draft guidance
4 February 2022 - Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment ...
Posted by Michael Wonder on 04 Feb 2022
Libmedly: world's 'most expensive' drug recommended for NHS use
4 February 2022 - The NHS has struck a confidential deal for what's thought to be the most expensive drug ...
Posted by Michael Wonder on 04 Feb 2022
EU watchdog says supports fast development of Omicron only vaccine
3 February 2022 - The European Union's drug regulator said on Thursday it would support a filing for approval of ...
Posted by Michael Wonder on 04 Feb 2022
Samsung Bioepis announces Health Canada approval of 150 mg single-use vial and 440 mg multi-dose vial of Ontruzant (SB3), trastuzumab biosimilar for the treatment of adults with early breast cancer, metastatic breast cancer and metastatic gastric cancer
2 February 2022 - 150 mg and 440 mg vial of Ontruzant are now approved in Canada. ...
Posted by Michael Wonder on 04 Feb 2022
Lawmakers grill key FDA official over controversial Alzheimer’s drug approval
3 February 2022 - The FDA can’t escape questions about Aduhelm. ...
Posted by Michael Wonder on 04 Feb 2022
Biden-Harris Administration will cover free over the counter COVID-19 tests through Medicare
3 February 2022 - As part of the Biden-Harris Administration’s ongoing efforts to expand Americans’ access to free testing, people in ...
Posted by Michael Wonder on 04 Feb 2022
BioCardia receives FDA breakthrough device designation for CardiAMP cell therapy system for heart failure
3 February 2022 - BioCardia today announced that the U.S. FDA has granted breakthrough device designation for the CardiAMP Cell ...
Posted by Michael Wonder on 03 Feb 2022
Novavax COVID-19 vaccine Nuvaxovid approved by MHRA
3 February 2022 - The vaccine has been approved after meeting the required safety, quality and effectiveness standards. ...
Posted by Michael Wonder on 03 Feb 2022
Britain fines firms $47 million over price surge for NHS nausea pill
3 February 2022 - Britain's competition watchdog on Thursday fined five firms a total of 35 million pounds ($47.5 million) ...
Posted by Michael Wonder on 03 Feb 2022
ICER releases draft evidence report on treatments for COVID-19
3 February 2022 - Public comment period now open until 3 March 2022; requests to make oral comment during public ...
Posted by Michael Wonder on 03 Feb 2022
Democrats must get their act together, starting with drug prices
3 February 2022 - It's certainly disappointing that President Biden's Build Back Better Act has stalled in the Senate. Democrats were ...
Posted by Michael Wonder on 03 Feb 2022
Lipocine announces its partner received FDA acceptance of NDA resubmission for Tlando
3 February 2022 - PDUFA target action date set for 28 March 2022. ...
Posted by Michael Wonder on 03 Feb 2022
ICER to assess treatments for amyotrophic lateral sclerosis
3 February 2022 - Report will be subject of Midwest CEPAC meeting in August 2022; draft scoping document open to ...
Posted by Michael Wonder on 03 Feb 2022
Weak krona exchange rates result in lower drug prices
3 February 2022 - The price of medicines in Sweden has fallen compared with other countries and is among the lowest ...
Posted by Michael Wonder on 03 Feb 2022
Timely intervention: first chronic kidney disease treatment in 20 years
3 February 2022 - Significant landmark as NICE recommends AstraZeneca's chronic kidney disease treatment Forxiga ...